Format

Send to

Choose Destination
Biochim Biophys Acta. 2012 Nov;1821(11):1443-52. doi: 10.1016/j.bbalip.2012.07.004. Epub 2012 Jul 20.

Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms.

Author information

1
Department of Metabolic Diseases, UMC Utrecht and Netherlands Metabolomics Centre, The Netherlands.

Abstract

The farnesoid X receptor (FXR) is a ligand-activated transcription factor belonging to the nuclear receptor (NR) superfamily. FXR plays an important role in positively regulating genes (transactivation) involved in bile acid homeostasis, fat and glucose metabolism. Recently, it has become clear that an additional important role for FXR consists of downregulating genes involved in inflammation. Because of this broad spectrum of regulated genes, therapeutically targeting FXR with full agonists will likely result in adverse side effects, in line with what is described for other NRs. It may therefore be necessary to develop selective FXR modulators. However, the molecular mechanisms that distinguish between FXR-mediated transactivation and transrepression are currently unknown. For other NRs, post-translational modifications such as SUMOylation and phosphorylation have been reported to be unique to either transactivation or transrepression. Here, we review current knowledge on post-translational regulation of FXR with respect to transactivation and transrepression. Ultimately, increased understanding of the different mechanisms of transactivation and transrepression of nuclear receptors will aid in the development of NR drugs with fewer side effects.

PMID:
22820415
DOI:
10.1016/j.bbalip.2012.07.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center